Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business Sort descending
  • Functional Area
  • Date Posted
Job Title Site Location Division Business Sort descending Functional Area Date Posted
Buyer - Corporate Spend Prague Czech Republic Operations CTS Procurement Oct 18, 2024
Buyer Prague Czech Republic Operations CTS Procurement Oct 18, 2024
IT Solution Delivery Sr. Manager for Medical Products Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 18, 2024
Manager, Digital Storytelling Remote Position (USA) USA Corporate Affairs CTS Communications & Public Affairs Oct 18, 2024
Associate Director, QC IT Technical Solution Delivery Ljubljana Slovenia Operations CTS Technology Transformation Oct 18, 2024
Assoc. Dir. DDIT APD CE Service Mgmt. INSURGENTES Mexico Operations CTS Technology Transformation Oct 18, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Associate, Record-to-Report Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance Jun 26, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Treasury Manager Moscow (City) Russian Fed. Finance CTS Audit & Finance Jun 20, 2024
R2R Accountant Moscow (City) Russian Fed. Finance CTS Audit & Finance Jul 25, 2024
Patient Engagement Lead İstanbul Kavacık Turkey Corporate Affairs CTS Communications & Public Affairs Sep 03, 2024
Hire to Retire Services Specialist Selangor Malaysia People & Organization CTS Human Resources Aug 19, 2024
R2R Senior Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Aug 19, 2024
Assoc. Dir. DDIT ISC SecOps VulnSvcs Hyderabad (Office) India Operations CTS Technology Transformation Aug 20, 2024
Associate Director for Information Security and Compliance, M&A Team Prague Czech Republic Operations CTS Technology Transformation Aug 20, 2024
Assoc. Dir. DDIT ISC VulnSvcs role Hyderabad (Office) India Operations CTS Technology Transformation Aug 20, 2024
ERP Assurance Senior Consultant-2 INSURGENTES Mexico Finance CTS Audit & Finance Aug 20, 2024
Assoc. Dir. DDIT Dev. Business Analyst, Global Clinical Operations Barcelona Gran Vía Spain Operations CTS Technology Transformation Aug 21, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance Oct 06, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Team Lead Medical Communications (Scientific Engagements) Dublin (Novartis Corporate Center (NOCC)) Ireland Operations CTS Research & Development Oct 09, 2024
Associate Director, Strategic Recruitment Marketing Hyderabad (Office) India People & Organization CTS Human Resources Oct 09, 2024
Security Solutions Architect (Mergers & Acquisitions) Prague Czech Republic Operations CTS Technology Transformation Oct 09, 2024
Human Capital Management | Global PMO (Temporary role 18 months) INSURGENTES Mexico People & Organization CTS Human Resources Oct 09, 2024
Assoc. Dir. DDIT ISC SecOps VulnSvcs Hyderabad (Office) India Operations CTS Technology Transformation Oct 09, 2024
Sr. Spec. DDIT IES O365 Sec. & Compl. Hyderabad (Office) India Operations CTS Technology Transformation Oct 09, 2024
Associate Director DDIT ISC Detection & Response Hyderabad (Office) India Operations CTS Technology Transformation Oct 09, 2024
Revenue Deduction & Accounting Statutory Lead Warsaw Poland Finance CTS Audit & Finance Oct 10, 2024
Lead Consultant Prague Czech Republic Operations CTS BD&L & Strategic Planning Oct 10, 2024
Senior Consultant Prague Czech Republic Operations CTS BD&L & Strategic Planning Oct 10, 2024
R2R Team Lead - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Oct 10, 2024
Clinical Sourcing Manager, R&D Hyderabad (Office) India Operations CTS Procurement Oct 10, 2024
Sr. Spec. DDIT GF Sol.Del. HCM Hyderabad (Office) India Operations CTS Technology Transformation Oct 10, 2024
UX/UI Designer Prague Czech Republic Operations CTS Technology Transformation Oct 10, 2024
LDC - Data Business Manager - Operations Prague Czech Republic Operations CTS Technical Operations Oct 10, 2024
Associate Director of Forensics Hyderabad (Office) India Operations CTS Technology Transformation Oct 10, 2024
Assoc. Dir. Solution Delivery - SAP FICO Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 10, 2024
Director, Marketing & Digital Data Solution Hyderabad (Office) India Operations CTS Marketing Oct 10, 2024
Director Data Stratagy Hyderabad (Office) India Operations CTS Marketing Oct 10, 2024
P2P Process Excellence INSURGENTES Mexico Operations CTS Audit & Finance Oct 02, 2024
Global FC&C Process Expert (Senior Manager) PIN-PCA Prague Czech Republic Finance CTS Audit & Finance Oct 03, 2024
P2P Service Delivery (SD) Lead NGSC INSURGENTES Mexico Finance CTS Audit & Finance Oct 07, 2024
Finance Control and Compliance US Manager INSURGENTES Mexico Finance CTS Audit & Finance Oct 08, 2024
General Accounting Manager INSURGENTES Mexico Finance CTS Audit & Finance Oct 09, 2024
Learning & Talent Central Services Specialist INSURGENTES Mexico People & Organization CTS Human Resources Oct 14, 2024
Coordinator, Global Program Management and Portfolio Excellence INSURGENTES Mexico Biomedical Research CTS Research & Development Oct 15, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only